oa CSIR Science Scope - Using biological expression systems to manufacture therapeutic peptides : oportunities
A proprietary biological expression system to manufacture therapeutic peptides is one of the latest CSIR inventions in life sciences. These peptides are generally manufactured by pharmaceutical companies through chemical synthesis and this route can be complex, costly and inefficient. Globally, the use of biological expression systems is finding favour as a low-cost, environmentally friendly alternative to traditional chemical processes. The HaloBiologix™ technology is being further developed at the CSIR and incubated as a potential new start-up venture.
Article metrics loading...